Variant · Snv
GUF1 NM_021927.3(GUF1):c.734+1G>A
CI-VAR-00226209Explore in graph →NM_021927.3:c.734+1G>AClinVar 1627617 rs141526764
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1627617 | Benign | criteria provided, multiple submitters, no conflicts | 2 | GUF1-related disorder; Thyroid cancer, nonmedullary, 1; Melanoma; Malignant tumor of urinary bladder; Hepatocellular carcinoma; Chronic lymphocytic leukemia/small lymphocytic lymphoma; Clear cell carcinoma of kidney; Colon adenocarcinoma; Sarcoma; Colorectal cancer; Gastric cancer; Thymoma; Adrenocortical carcinoma, hereditary; Papillary renal cell carcinoma type 1; Malignant tumor of esophagus; Familial cancer of breast; Cervical cancer | germline | 4 | Feb 02, 2026 | clinvar |